Synthesis and biological evaluation of novel 6,11-dihydro-5H-benzo[e] pyrimido- [5,4-b][1,4]diazepine derivatives as potential c-Met inhibitors

被引：17
|
作者：
Huang, Daowei [1 ,2 ]
Huang, Lei [1 ,2 ]
Zhang, Qingwei [1 ,2 ]
Li, Jianqi [1 ,2 ]
机构：
[1] Shanghai Inst Pharmaceut Ind, Novel Technol Ctr Pharmaceut Chem, Shanghai 201203, Peoples R China
[2] Shanghai Engn Res Ctr Pharmaceut Proc, Shanghai 201203, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 140卷
基金：
中国国家自然科学基金;
关键词：
c-Met; tyrosine kinase; Diazepine derivatives; Synthesis; Antitumor; RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; SMALL-MOLECULE INHIBITOR; ANTITUMOR-ACTIVITY; DUAL INHIBITORS; IN-VIVO; DESIGN; MOIETY; DISCOVERY; BEARING;
D O I：
10.1016/j.ejmech.2017.08.060
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Over expression of c-Met tyrosine kinase is known to promote tumorigenesis and metastasis, as well as to cause therapeutic resistance. Herein a series of novel 6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4] diazepine derivatives were designed, synthesised and evaluated for their c-Met kinase inhibition. Compounds 17e, 17f, 18a, and 18b were further examined for their anti-proliferative activities against four typical cancer cell lines (PC-3, Panc-1, HepG2, and Caki-1). The promising compound 17f was identified as a multi-target receptor tyrosine kinase inhibitor, which also displayed favourable pharmacokinetic properties in rats, had an acceptable safety profile in preclinical studies, and significant anti tumour activity in the Caki-1 tumour xenograft model. (C) 2017 Published by Elsevier Masson SAS.
引用
收藏
页码：212 / 228
页数：17
相关论文
共 50 条
  • [1] Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1
    Deng, Xianming
    Yang, Qingkai
    Kwiatkowski, Nicholas
    Sim, Taebo
    McDermott, Ultan
    Settleman, Jeffrey E.
    Lee, Jiing-Dwan
    Gray, Nathanael S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03): : 195 - 200
  • [2] Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one Scaffold
    Ferguson, Fleur M.
    Liu, Yan
    Harshbarger, Wayne
    Huang, Ling
    Wang, Jinhua
    Deng, Xianming
    Capuzzi, Stephen J.
    Muratov, Eugene N.
    Tropsha, Alexander
    Muthuswamy, Senthil
    Westover, Kenneth D.
    Gray, Nathanael S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7817 - 7826
  • [3] Structure-based design, synthesis, and evaluation of 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel c-Met inhibitors
    Zhang, Li
    Zhang, Beichen
    Zhao, Jingyun
    Zhi, Yanle
    Wang, Lu
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 942 - 951
  • [4] Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors
    Zhao, Junjun
    Fang, Lei
    Zhang, Xiaobing
    Liang, Yan
    Gou, Shaohua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3483 - 3493
  • [5] Monoclinic and orthorhombic forms of (RS)-(E)-4-[2-(4-chlorobenzylidene)hydrazinyl]-6,11-dimethyl-6,11-dihydro-5H-benzo[b]pyrimido[5,4-f]azepine: synthesis, concomitant polymorphism and supramolecular assembly mediated by C-H•••N, C-H•••π(arene) and C-Cl•••π(arene) interactions
    Acosta Quintero, Lina M.
    Palma, Alirio
    Choquesillo-Lazarte, Duane
    Cobo, Justo
    Glidewell, Christopher
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2019, 75 : 686 - +
  • [6] Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones
    Deng, Xianming
    Elkins, Jonathan M.
    Zhang, Jinwei
    Yang, Qingkai
    Erazo, Tatiana
    Gomez, Nestor
    Choi, Hwan Geun
    Wang, Jinhua
    Dzamko, Nicolas
    Lee, Jiing-Dwan
    Sim, Taebo
    Kim, NamDoo
    Alessi, Dario R.
    Lizcano, Jose M.
    Knapp, Stefan
    Gray, Nathanael S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 758 - 767
  • [7] Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo [1,5-a] pyrimidine derivatives as potential c-Met inhibitors
    Luo, Guolin
    Ma, Yanxia
    Liang, Xintong
    Xie, Guoquan
    Luo, Yingqi
    Zha, Dailong
    Wang, Sheng
    Yu, Lihong
    Zheng, Xuehua
    Wu, Wenhao
    Zhang, Chao
    BIOORGANIC CHEMISTRY, 2020, 104
  • [8] Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity
    Zhang, Li
    Zhao, Jingyun
    Zhang, Beichen
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 809 - 816
  • [9] A Facile and Chemoselective Synthesis of Novel Pyrimido[5,4-b][1,4]thiazines by exo-dig Iodocyclization Reactions
    Sharma, Rashmi
    Mohan, Chander
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (03) : 1833 - 1839
  • [10] Synthesis of 5,6-dihydro-4H-benzo[d]isoxazol-7-one and 5,6-dihydro-4H-isoxazolo[5,4-c]pyridin-7-one Derivatives as Potential Hsp90 Inhibitors
    Musso, Loana
    Cincinelli, Raffaella
    Giannini, Giuseppe
    Manetti, Fabrizio
    Dallavalle, Sabrina
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (05) : 1030 - 1035
12345